Speech-Language Pathologists in Natchitoches, LA Accepting Medicare

11 Speech-Language Pathologists found. Showing 1 - 11

Mrs. Gwendolyn R Cupp, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 112 Daniel Cir, Natchitoches, LA 71457 Phone: 318-471-3935

St. Gabriel Speech-language Pathology Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1002 E 5th St, Natchitoches, LA 71457 Phone: 318-471-5671

Lisa Brooke Reeves, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 740 Keyser Ave.,, Suite E, Natchitoches, LA 71457 Phone: 318-214-0088    Fax: 318-214-9009

Amelia Nicole Sines, MCD CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1002 E 5th St, Natchitoches, LA 71457 Phone: 318-471-5671

Lauren Kay Potts Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 Royal St, Natchitoches, LA 71457 Phone: 318-352-2358

Mrs. Mary Hannah Toups, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 781 Keyser Ave, Natchitoches, LA 71457 Phone: 318-352-8296

Randee Knapp Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Isadore St, Natchitoches, LA 71457 Phone: 318-238-2810

Emily Yaghoubian, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Live Oak Cir, Natchitoches, LA 71457 Phone: 318-238-3755

Bethany Troquille, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Williams Ave, Natchitoches, LA 71457 Phone: 318-214-0088    Fax: 318-214-9009

Virginia Ratliff Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 216 Melrose Ave, Natchitoches, LA 71457 Phone: 318-357-8535

Aimee Winn, M.S., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 830 Collins Rd, Natchitoches, LA 71457 Phone: 318-332-6738

News Archive

Moffitt study identifies new drug target that may reduce GVHD risk

Stem cell transplants can cure patients with high-risk leukemia or lymphoma. Graft-versus-host disease is a potentially life-threatening side effect that occurs when the donor's immune cells attack the recipient's normal tissues.

Virginia Tech releases adult football helmet ratings to help reduce risk of concussion

Virginia Tech released today the results of its 2013 adult football helmet ratings, designed to identify differences between the abilities of helmets to reduce the risk of concussion. A total of four helmets achieved a 5 star mark, which is the highest rating awarded by the Virginia Tech Helmet Ratings-.

Women ages 35+ are at decreased risk of having child with congenital malformation

In a study to be presented on Feb. 6 at 3 p.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report that women ages 35 and older are at a decreased risk of having a child with a major congenital malformation, after excluding chromosomal abnormalities.

Insulin resistance from obesity leads to lower cognitive performance in children: Research

A study by researchers at NYU Langone Medical Center have found that obese adolescents with type 2 diabetes have diminished cognitive performance and subtle abnormalities in the brain as detected by Magnetic Resonance Imaging (MRI). Identification of cognitive impairments as a complication of type 2 diabetes emphasizes the importance of addressing issues of inactivity and obesity, two important risk factors for the development of the disease among the young.

AcelRx prices initial public offering at $5.00 per share

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced the pricing of its initial public offering of 8 million shares of common stock at $5.00 per share. All of the common stock will be sold by AcelRx.

Read more Medical News

› Verified 7 days ago